Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • State Department Announces 28th Experience America Visit to Boston World News
  • Artificial Intelligence (AI) In Aerospace And Defense Market Projected to Reach $48.76 Billion with 13.6% CAGR by 2029 Aviation
  • PacerPro Solidifies Commitment to Law Firm Security With SOC 2 Compliance and SSO Integrations Business
  • Global CBD Oil And CBD Consumer Health Products Market Is Projected To Grow At A 25% Rate Through The Forecast Period World News
  • United States Special Representative for Racial Equity and Justice Cormier Smith’s Travel to Jordan World News
  • MetaQuotes Has Launched a Fundamentally New WebTerminal Business
  • Elan Future Pioneers Accessible Energy on the Blockchain World News
  • American Management University Set to Host Its Premier Physical Graduation with Festivities and Award-Giving Ceremony World News

Dr. Eugene Reinersman Highlights Innovative Use of Ketamine in Treating Depression

Posted on November 30, 2024 By NewsEditor

Broomfield, CO – Dr. Eugene Reinersman, a distinguished provider at Khrysalis Infusion, has unveiled crucial insights about ketamine’s potential in treating depression, challenging preconceived notions surrounding this powerful substance. With over 17 years of experience as a board-certified emergency medicine physician, Dr. Reinersman is pioneering the use of ketamine as a viable therapy for individuals grappling with depression.

Traditionally known as “Special K,” a party drug, ketamine has emerged as a revolutionary solution for mental health issues when administered in controlled doses. The dual approach of ketamine and its derivative, esketamine, are proving to be life-changing for many who have felt overwhelmed by their struggle with depression.

“Ketamines’ rapid therapeutic effects bring hope to patients who have tried multiple treatments without success,” said Dr. Reinersman. “At Khrysalis Infusion, we are committed to offering cutting-edge, evidence-based therapies that prioritize the well-being and recovery of our patients. It’s a privilege to provide an option capable of transforming lives.”

Khrysalis Infusion offers comprehensive ketamine therapy in Colorado to address a wide range of mental health conditions, including anxiety, PTSD, and chronic pain. By administering ketamine through controlled intravenous infusions under certified medical supervision, the clinic aims to alleviate symptoms quickly and effectively, empowering patients to regain control over their mental and physical health.

Khrysalis Infusion is dedicated not only to innovative Ketamine therapy but also to providing compassionate and personalized care. Patients receive ongoing support through every stage of their healing process, ensuring a safe and reassuring environment conducive to lasting improvements in mental health.

For more information about ketamine therapy and Khrysalis Infusion’s range of treatments, visit khrysalisinfusion.com or contact us to schedule a free consultation.

About Khrysalis Infusion:

Khrysalis Infusion is a leading center in Broomfield, Colorado, specializing in novel therapies for mental health conditions. Our mission is to transform lives by providing hope and healing through evidence-based practices. We strive to empower individuals to achieve a state of mental and physical wellness, offering a unique blend of cutting-edge technology and compassionate care.

Source:

About Khrysalis Infusion

Experience transformation with ketamine and infusion therapy under expert care. Our skilled clinicians begin with a thorough assessment, ensuring safety and establishing a tailored care program for each patient. Our compassionate team will guide you through your infusion therapy experience.

Contact Khrysalis Infusion

413 Summit Blvd #204

Broomfield

CO 80021

United States

303.284.9802

Website:

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

November 21, 2024, 20:35 GMT


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as Dr. Eugene Reinersman Highlights Innovative Use of Ketamine in Treating Depression

World News

Post navigation

Previous Post: Hybrid Electric Aircrafts Global Market To Reach $4.35 Billion By 2028
Next Post: The Hydroponics Fertilizer Additive Market Is Projected To Reach $6.2 Billion By 2028, Growing At A CAGR Of 7.6%

Related Posts

  • The Gene Panel Reconciliation Services Market is projected to grow to USD 2.37 Bn by 2030, expanding at a CAGR of 12.3% World News
  • War Day 196: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Secretary Blinken’s Travel to Chicago, Illinois World News
  • Comprehensive Report on the Aircraft Cabin Interior Market: Opportunities and Challenges World News
  • War in Ukraine, Analytics. Day 1461: What are Zaluzhny and Zelensky Guilty Of? Arestovych, Shelest. World News
  • Nonprofit TechnoServe Adds Global Business Expert Olusegun Aganga to its Board of Directors World News
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • UNIFY.C2 Integrates Skycope RF Drone Detection Technology into Its Single Picture Command-and-Control PlatformJuly 23, 2026
  • Suncoast Web Marketing Earns Four Best of Florida Nominations as Demand Grows for Website Consulting ServicesJuly 22, 2026
  • GT Experience by Kenichi Mizuno Wins Bronze in A’ 3D Printing Industry AwardsJuly 22, 2026
  • Hephae Energy Technology Raises $17.8 Million for Commercial Deployment of Superhot Drilling Tech to Advance GeothermalJuly 21, 2026
  • Vero Beach’s Barrier Island Rides the 2026 Luxury SurgJuly 21, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Runway Safety Meetings Scheduled at Approximately 90 Airports Aviation
  • New Compensation Report Reveals How Salaries and Bonuses Are Set for Corporate Innovation and Strategy Leaders Business
  • Rev. Werner Trapp BBR Unveils New Book, “From the End Time to Heaven”
    Rev. Werner Trapp BBR Unveils New Book, “From the End Time to Heaven” World News
  • Day 453: war diaries w/Former Advisor to Ukraine President, Intel Officer  @arestovych  & #Feygin
    Day 453: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Biden-Harris Administration Announces $110 Million in Bipartisan Infrastructure Law Funding to Improve Safety and Efficiency at 71 Airports Aviation
  • Assistant Secretary Noyes Travel to Belgium World News
  • Edmond’s Award-Winning McCann’s Roofing Opens New Oklahoma City Office Business
  • EyeQue Gives Back Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .